Chemotherapeutic Inhibitors of the Enzymes of the de Novo Pyrimidine Pathway

Thomas W. Kensler, David A. Cooney

Research output: Contribution to journalArticle

Abstract

This chapter discusses the chemotherapeutic inhibitors of the enzymes of the de novo pyrimidine pathway. The requirement for pyrimidines is ubiquitously distributed throughout the spectrum of living organisms and can be fulfilled by two synthetic pathways: a de novo and a salvage pathway. Although extensive information is available in the literature on techniques for measuring the activities of the enzymes of the pyrimidine biosynthetic pathway, it is the purpose of the present Appendix to evaluate these techniques critically, to suggest improvements and alternative analytical strategies, and to outline means for assessing the concentrations of the substrates or products of the six reactions under consideration in normal as well as neoplastic tissues.

Original languageEnglish (US)
Pages (from-to)273-352
Number of pages80
JournalAdvances in Pharmacology
Volume18
Issue numberC
DOIs
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Chemotherapeutic Inhibitors of the Enzymes of the de Novo Pyrimidine Pathway'. Together they form a unique fingerprint.

  • Cite this